Five-year comparison of antidepressant monotherapy

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Psychology

Background:

• Unipolar depression is a prevalent mood disorder requiring effective long-term management.
• Maintaining remission is crucial for improving patient outcomes and quality of life.
• Antidepressant monotherapy is a common treatment approach for unipolar depression.

Purpose of the Study:

• To compare the effectiveness of various antidepressants in sustaining remission among outpatients with unipolar depression.
• To identify which antidepressant medications are most effective in preventing relapse.
• To analyze patient data for factors influencing long-term treatment success.

Main Methods:

• Retrospective chart review of 2475 patients in a rural private psychiatric practice.
• Inclusion criteria focused on patients with unipolar depression achieving remission on monotherapy.
• Data collected included demographics, depression scores (Carroll Depression Rating Scale), and medication history.

Main Results:

• 346 patients met inclusion criteria; average remission time was 0.36 years with 0.28 relapses/year.
• Escitalopram and sertraline showed the shortest time to remission (0.24 and 0.27 years).
• Sertraline demonstrated the longest remission duration (62% at 5 years) and lowest relapse time (8%).

Conclusions:

• Sertraline is highly effective for maintaining remission in unipolar depression.
• Paroxetine also shows promise in preventing relapse, though to a lesser extent than sertraline.
• These findings support sertraline as a preferred option for long-term unipolar depression management.